Annexon Inc
For the period ended Dec 31, 2023. Filed Mar 26, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 26, 2024
ANNX$4.21-0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity
(in thousands, except share amounts)
| Common Stock · AdditionalPaid-In · Accumulated OtherComprehensive · Accumulated · TotalStockholders’ | ||||||
|---|---|---|---|---|---|---|
| Shares | Cost | Capital | Loss | Deficit | Equity | |
| Balances as of December 31, 2021 | 38,560,854 | $39 | $528,365 | $(180) | $(296,315) | $231,909 |
| Stock-based compensation | — | — | 18,516 | — | — | 18,516 |
| Stock option exercises | 15,364 | — | 80 | — | — | 80 |
| Issuance of common stock, pre-funded warrants and common warrants, net of issuance costs of $7,988 | 9,013,834 | 9 | 122,479 | — | — | 122,488 |
| Issuance of common stock per Employee Stock Purchase Plan purchase | 121,126 | — | 340 | — | — | 340 |
| Restricted stock vested in the period | 11,817 | — | — | — | — | — |
| Other comprehensive loss | — | — | — | (192) | — | (192) |
| Net loss | — | — | — | — | (141,947) | (141,947) |
| Balances as of December 31, 2022 | 47,722,995 | 48 | 669,780 | (372) | (438,262) | 231,194 |
| Stock-based compensation | — | — | 18,183 | — | — | 18,183 |
| Stock option exercises | 76,888 | — | 145 | — | — | 145 |
| Exercise of pre-funded warrants | 2,582,557 | 3 | (3) | — | — | — |
| Issuance of common stock to related party, net of issuance costs of $525 | 2,646,458 | 2 | 17,468 | — | — | 17,470 |
| Issuance of common stock and pre- funded warrants, net of issuance cost of $8,014 | 25,035,000 | 25 | 116,977 | — | — | 117,002 |
| Issuance of common stock per Employee Stock Purchase Plan purchase | 133,105 | — | 479 | — | — | 479 |
| Restricted stock vested in the period | 172,096 | — | — | — | — | — |
| Other comprehensive gain | — | — | — | 320 | — | 320 |
| Net loss | — | — | — | — | (134,237) | (134,237) |
| Balances as of December 31, 2023 | 78,369,099 | $78 | $823,029 | $(52) | $(572,499) | $250,556 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.